✦ LIBER ✦

Low dose capecitabine plus weekly paclitaxel in patients with metastatic breast cancer: a multicenter phase II study KBCSG-0609

✍ Scribed by Tetsuya Taguchi, Daigo Yamamoto, Norikazu Masuda…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

484 Impact of 4-weekly capecitabine plus

✍ D. Yamamoto; T. Taguchi; N. Masuda; T. Nakayama; T. Nagata; M. Nomura; K. Yoshid 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB

463 A multicenter phase II study of cape

✍ W. Gradishar; L. Meza; T. Hill; D. Samid; Y.-M. Chen; B. Amin 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Preliminary results of a Phase II study

✍ M. Hayashi; Oyama; M. Sunagawa 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Phase II Study of Weekly Docetaxel and C

✍ Ewa Mrozek; Bhuvaneswari Ramaswamy; Donn Young; Chris A. Rhoades; Kari Kendra; J 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 111 KB

Weekly paclitaxel plus trastuzumab in me

✍ Matthias John, Axel Hinke, Martina Stauch, Heiner Wolf, Benno Mohr, Hans-Joachim 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 197 KB

Chemoneuroendocrine therapy of metastati

✍ P. Lissoni; G. Tancini; F. Paolorossi; M. Mandalà; A. Ardizzoia; F. Malugani; L. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 379 KB